SCOPUS 정보 검색 플랫폼

Journal of Experimental Medicine

Volumn 210, Issue 9, 2013, Pages 1647-1651

Fcγ receptors enable anticancer action of proapoptotic and immune-modulatory antibodies

(2) Kim, Jeong M a Ashkenazi, Avi a

a GENENTECH INC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; MEMBRANE ANTIGEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS; APOPTOSIS; HUMANS; IMMUNOLOGIC FACTORS; RECEPTORS, IGG; T-LYMPHOCYTES, REGULATORY;

EID: 84884271341 PISSN: 00221007 EISSN: 15409538 Source Type: Journal
DOI: 10.1084/jem.20131625 Document Type: Article

Times cited : (34)

References (34)

1
- 0026769620
- Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes
- Amigorena, S., C. Bonnerot, J.R. Drake, D. Choquet, W. Hunziker, J.G. Guillet, P. Webster, C. Sautes, I. Mellman, and W.H. Fridman. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science. 256:1808-1812. http://dx.doi .org/10.1126/science.1535455
- (1992) Science , vol.256 , pp. 1808-1812
- Amigorena, S.¹ Bonnerot, C.² Drake, J.R.³ Choquet, D.⁴ Hunziker, W.⁵ Guillet, J.G.⁶ Webster, P.⁷ Sautes, C.⁸ Mellman, I.⁹ Fridman, W.H.¹⁰

2
- 84884229186
- Activating Fc? receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies
- Bulliard, Y., R. Jolicouer, M. Windman, S.M. Rue, S. Ettenberg, D.A. Knee, N.S. Wilson, G. Dranoff, and J.L. Brogdon. 2013. Activating Fc? receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. J. Exp. Med. 210:1685-1693.
- (2013) J. Exp. Med. , vol.210 , pp. 1685-1693
- Bulliard, Y.¹ Jolicouer, R.² Windman, M.³ Rue, S.M.⁴ Ettenberg, S.⁵ Knee, D.A.⁶ Wilson, N.S.⁷ Dranoff, G.⁸ Brogdon, J.L.⁹

3
- 33646352962
- Potent antibody therapeutics by design
- Carter, P.J. 2006. Potent antibody therapeutics by design. Nat. Rev. Immunol. 6:343-357. http:// dx.doi.org/10.1038/nri1837
- (2006) Nat. Rev. Immunol. , vol.6 , pp. 343-357
- Carter, P.J.¹

4
- 0031405867
- Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells
- Chambers, C.A., T.J. Sullivan, and J.P. Allison. 1997. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity. 7:885- 895. http://dx.doi.org/10.1016/S1074-7613 (00)80406-9
- (1997) Immunity. , vol.7
- Chambers, C.A.¹ Sullivan, T.J.² Allison, J.P.³

5
- 77955515915
- Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy
- Coe, D., S. Begom, C. Addey, M. White, J. Dyson, and J.G. Chai. 2010. Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy. Cancer Immunol. Immunother. 59:1367-1377. http:// dx.doi.org/10.1007/s00262-010-0866-5
- (2010) Cancer Immunol. Immunother. , vol.59 , pp. 1367-1377
- Coe, D.¹ Begom, S.² Addey, C.³ White, M.⁴ Dyson, J.⁵ Chai, J.G.⁶

6
- 0035451391
- Inflammation in autoimmunity: receptors for IgG revisited
- Dijstelbloem, H.M., J.G. van de Winkel, and C.G. Kallenberg. 2001. Inflammation in autoimmunity: receptors for IgG revisited. Trends Immunol. 22:510-516. http://dx.doi.org/ 10.1016/S1471-4906(01)02014-2
- (2001) Trends Immunol. , vol.22 , pp. 510-516
- Dijstelbloem, H.M.¹ van de Winkel, J.G.² Kallenberg, C.G.³

7
- 0036144888
- Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo
- Gavin, M.A., S.R. Clarke, E. Negrou, A. Gallegos, and A. Rudensky. 2002. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3:33-41. http://dx.doi .org/10.1038/ni743
- (2002) Nat. Immunol. , vol.3 , pp. 33-41
- Gavin, M.A.¹ Clarke, S.R.² Negrou, E.³ Gallegos, A.⁴ Rudensky, A.⁵

8
- 77954801079
- Improved survival with ipilimumab in patients with metastatic melanoma
- Hodi, F.S., S.J. O'Day, D.F. McDermott, R.W. Weber, J.A. Sosman, J.B. Haanen, R. Gonzalez, C. Robert, D. Schadendorf, J.C. Hassel, et al. 2010. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363:711-723. http://dx.doi.org/10 .1056/NEJMoa1003466
- (2010) N. Engl. J. Med. , vol.363 , pp. 711-723
- Hodi, F.S.¹ O'Day, S.J.² McDermott, D.F.³ Weber, R.W.⁴ Sosman, J.A.⁵ Haanen, J.B.⁶ Gonzalez, R.⁷ Robert, C.⁸ Schadendorf, D.⁹ Hassel, J.C.¹⁰

9
- 61649087668
- Glycosylation as a strategy to improve antibody-based therapeutics
- Jefferis, R. 2009. Glycosylation as a strategy to improve antibody-based therapeutics. Nat. Rev. Drug Discov. 8:226-234. http://dx.doi.org/ 10.1038/nrd2804
- (2009) Nat. Rev. Drug Discov. , vol.8 , pp. 226-234
- Jefferis, R.¹

10
- 84859416933
- Regulatory T cells: mechanisms of differentiation and function
- Josefowicz, S.Z., L.F. Lu, and A.Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564. http://dx.doi.org/10.1146/annurev .immunol.25.022106.141623
- (2012) Annu. Rev. Immunol. , vol.30 , pp. 531-564
- Josefowicz, S.Z.¹ Lu, L.F.² Rudensky, A.Y.³

11
- 25844517914
- Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
- Ko, K., S. Yamazaki, K. Nakamura, T. Nishioka, K. Hirota, T. Yamaguchi, J. Shimizu, T. Nomura, T. Chiba, and S. Sakaguchi. 2005. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J. Exp. Med. 202:885-891. http://dx.doi.org/10 .1084/jem.20050940
- (2005) J. Exp. Med. , vol.202 , pp. 885-891
- Ko, K.¹ Yamazaki, S.² Nakamura, K.³ Nishioka, T.⁴ Hirota, K.⁵ Yamaguchi, T.⁶ Shimizu, J.⁷ Nomura, T.⁸ Chiba, T.⁹ Sakaguchi, S.¹⁰

12
- 0029120245
- CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
- Krummel, M.F., and J.P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459-465. http://dx.doi.org/10.1084/ jem.182.2.459
- (1995) J. Exp. Med. , vol.182 , pp. 459-465
- Krummel, M.F.¹ Allison, J.P.²

13
- 33645218704
- Engineered antibody Fc variants with enhanced effector function
- Lazar, G.A., W. Dang, S. Karki, O. Vafa, J.S. Peng, L. Hyun, C. Chan, H.S. Chung, A. Eivazi, S.C. Yoder, et al. 2006. Engineered antibody Fc variants with enhanced effector function. Proc. Natl. Acad. Sci. USA. 103:4005-4010. http:// dx.doi.org/10.1073/pnas.0508123103
- (2006) Proc. Natl. Acad. Sci. USA. , vol.103 , pp. 4005-4010
- Lazar, G.A.¹ Dang, W.² Karki, S.³ Vafa, O.⁴ Peng, J.S.⁵ Hyun, L.⁶ Chan, C.⁷ Chung, H.S.⁸ Eivazi, A.⁹ Yoder, S.C.¹⁰

14
- 80051885494
- Inhibitory Fcγ receptor engagement drives adjuvant and antitumor activities of agonistic CD40 antibodies
- Li, F., and J.V. Ravetch. 2011. Inhibitory Fcγ receptor engagement drives adjuvant and antitumor activities of agonistic CD40 antibodies. Science. 333:1030-1034. http://dx.doi.org/ 10.1126/science.1206954
- (2011) Science. , vol.333 , pp. 1030-1034
- Li, F.¹ Ravetch, J.V.²

15
- 0036195161
- CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid- induced TNF receptor
- McHugh, R.S., M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, M. Collins, and M.C. Byrne. 2002. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid- induced TNF receptor. Immunity. 16:311-323. http://dx.doi.org/10.1016/S1074- 7613(02)00280-7
- (2002) Immunity. , vol.16 , pp. 311-323
- McHugh, R.S.¹ Whitters, M.J.² Piccirillo, C.A.³ Young, D.A.⁴ Shevach, E.M.⁵ Collins, M.⁶ Byrne, M.C.⁷

16
- 28544449847
- Divergent immunoglobulin g subclass activity through selective Fc receptor binding
- Nimmerjahn, F., and J.V. Ravetch. 2005. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science. 310:1510-1512. http://dx.doi.org/10.1126/ science.1118948
- (2005) Science. , vol.310 , pp. 1510-1512
- Nimmerjahn, F.¹ Ravetch, J.V.²

17
- 30444461383
- Fcgamma receptors: old friends and new family members
- Nimmerjahn, F., and J.V. Ravetch. 2006. Fcgamma receptors: old friends and new family members. Immunity. 24:19-28. http://dx.doi.org/ 10.1016/j.immuni.2005.11.010
- (2006) Immunity. , vol.24 , pp. 19-28
- Nimmerjahn, F.¹ Ravetch, J.V.²

18
- 37549036732
- Fcgamma receptors as regulators of immune responses
- Nimmerjahn, F., and J.V. Ravetch. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8:34-47. http://dx.doi .org/10.1038/nri2206
- (2008) Nat. Rev. Immunol. , vol.8 , pp. 34-47
- Nimmerjahn, F.¹ Ravetch, J.V.²

19
- 77954721060
- Regulatory T cells in tumor immunity
- Nishikawa, H., and S. Sakaguchi. 2010. Regulatory T cells in tumor immunity. Int. J. Cancer. 127:759-767.
- (2010) Int. J. Cancer. , vol.127 , pp. 759-767
- Nishikawa, H.¹ Sakaguchi, S.²

20
- 48249103057
- Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation
- Onishi, Y., Z. Fehervari, T. Yamaguchi, and S. Sakaguchi. 2008. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA. 105:10113-10118. http://dx.doi.org/10.1073/pnas.0711106105
- (2008) Proc. Natl. Acad. Sci. USA. , vol.105 , pp. 10113-10118
- Onishi, Y.¹ Fehervari, Z.² Yamaguchi, T.³ Sakaguchi, S.⁴

21
- 0036670565
- Engineering therapeutic antibodies for improved function
- Presta, L.G., R.L. Shields, A.K. Namenuk, K. Hong, and Y.G. Meng. 2002. Engineering therapeutic antibodies for improved function. Biochem. Soc. Trans. 30:487-490. http:// dx.doi.org/10.1042/BST0300487
- (2002) Biochem. Soc. Trans. , vol.30 , pp. 487-490
- Presta, L.G.¹ Shields, R.L.² Namenuk, A.K.³ Hong, K.⁴ Meng, Y.G.⁵

22
- 1642379813
- GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations
- Ronchetti, S., O. Zollo, S. Bruscoli, M. Agostini, R. Bianchini, G. Nocentini, E. Ayroldi, and C. Riccardi. 2004. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur. J. Immunol. 34:613-622. http://dx.doi.org/10.1002/eji .200324804
- (2004) Eur. J. Immunol. , vol.34 , pp. 613-622
- Ronchetti, S.¹ Zollo, O.² Bruscoli, S.³ Agostini, M.⁴ Bianchini, R.⁵ Nocentini, G.⁶ Ayroldi, E.⁷ Riccardi, C.⁸

23
- 33750835115
- Nonfucosylated therapeutic antibodies as nextgeneration therapeutic antibodies
- Satoh, M., S. Iida, and K. Shitara. 2006. Nonfucosylated therapeutic antibodies as nextgeneration therapeutic antibodies. Expert Opin. Biol. Ther. 6:1161-1173. http://dx.doi.org/ 10.1517/14712598.6.11.1161
- (2006) Expert Opin. Biol. Ther. , vol.6 , pp. 1161-1173
- Satoh, M.¹ Iida, S.² Shitara, K.³

24
- 0036170938
- Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
- Shimizu, J., S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135-142. http://dx.doi.org/10 .1038/ni759
- (2002) Nat. Immunol. , vol.3 , pp. 135-142
- Shimizu, J.¹ Yamazaki, S.² Takahashi, T.³ Ishida, Y.⁴ Sakaguchi, S.⁵

25
- 84884271914
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
- Simpson, T.R., F. Li, W. Montalvo-Ortiz, M.A. Sepulveda, K. Bergerhoff, F. Arce, C. Roddie, J.Y. Henry, H. Yagita, J.D. Wolchok, et al. 2013. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J. Exp. Med. 210:1695-1710.
- (2013) J. Exp. Med. , vol.210 , pp. 1695-1710
- Simpson, T.R.¹ Li, F.² Montalvo-Ortiz, W.³ Sepulveda, M.A.⁴ Bergerhoff, K.⁵ Arce, F.⁶ Roddie, C.⁷ Henry, J.Y.⁸ Yagita, H.⁹ Wolchok, J.D.¹⁰

26
- 84859991126
- Mouse model recapitulating human Fcγ receptor structural and functional diversity
- Smith, P., D.J. DiLillo, S. Bournazos, F. Li, and J.V. Ravetch. 2012. Mouse model recapitulating human Fcγ receptor structural and functional diversity. Proc. Natl. Acad. Sci. USA. 109:6181-6186. http://dx.doi.org/ 10.1073/pnas.1203954109
- (2012) Proc. Natl. Acad. Sci. USA. , vol.109 , pp. 6181-6186
- Smith, P.¹ DiLillo, D.J.² Bournazos, S.³ Li, F.⁴ Ravetch, J.V.⁵

27
- 6344279933
- Engagement of glucocorticoid- induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells
- Stephens, G.L., R.S. McHugh, M.J. Whitters, D.A. Young, D. Luxenberg, B.M. Carreno, M. Collins, and E.M. Shevach. 2004. Engagement of glucocorticoid- induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J. Immunol. 173:5008-5020.
- (2004) J. Immunol. , vol.173 , pp. 5008-5020
- Stephens, G.L.¹ McHugh, R.S.² Whitters, M.J.³ Young, D.A.⁴ Luxenberg, D.⁵ Carreno, B.M.⁶ Collins, M.⁷ Shevach, E.M.⁸

28
- 0028867420
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
- Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547. http:// dx.doi.org/10.1016/1074-7613(95)90125-6
- (1995) Immunity. , vol.3 , pp. 541-547
- Tivol, E.A.¹ Borriello, F.² Schweitzer, A.N.³ Lynch, W.P.⁴ Bluestone, J.A.⁵ Sharpe, A.H.⁶

29
- 0345598872
- Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells
- Tone, M., Y. Tone, E. Adams, S.F. Yates, M.R. Frewin, S.P. Cobbold, and H. Waldmann. 2003. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA. 100: 15059-15064. http://dx.doi.org/10.1073/ pnas.2334901100.
- (2003) Proc. Natl. Acad. Sci. USA. , vol.100 , pp. 15059-15064
- Tone, M.¹ Tone, Y.² Adams, E.³ Yates, S.F.⁴ Frewin, M.R.⁵ Cobbold, S.P.⁶ Waldmann, H.⁷

30
- 4644342928
- Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells
- Turk, M.J., J.A. Guevara-Patiño, G.A. Rizzuto, M.E. Engelhorn, S. Sakaguchi, and A.N. Houghton. 2004. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med. 200:771-782. http://dx.doi.org/10.1084/jem.20041130
- (2004) J. Exp. Med. , vol.200 , pp. 771-782
- Turk, M.J.¹ Guevara-Patiño, J.A.² Rizzuto, G.A.³ Engelhorn, M.E.⁴ Sakaguchi, S.⁵ Houghton, A.N.⁶

31
- 0028484545
- CTLA- 4 can function as a negative regulator of T cell activation
- Walunas, T.L., D.J. Lenschow, C.Y. Bakker, P.S. Linsley, G.J. Freeman, J.M. Green, C.B. Thompson, and J.A. Bluestone. 1994. CTLA- 4 can function as a negative regulator of T cell activation. Immunity. 1:405-413. http:// dx.doi.org/10.1016/1074-7613(94)90071-X
- (1994) Immunity. , vol.1 , pp. 405-413
- Walunas, T.L.¹ Lenschow, D.J.² Bakker, C.Y.³ Linsley, P.S.⁴ Freeman, G.J.⁵ Green, J.M.⁶ Thompson, C.B.⁷ Bluestone, J.A.⁸

32
- 0028791059
- Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
- Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:985-988. http://dx.doi.org/10.1126/ science.270.5238.985
- (1995) Science. , vol.270 , pp. 985-988
- Waterhouse, P.¹ Penninger, J.M.² Timms, E.³ Wakeham, A.⁴ Shahinian, A.⁵ Lee, K.P.⁶ Thompson, C.B.⁷ Griesser, H.⁸ Mak, T.W.⁹

33
- 78651466506
- An Fcγ receptor- dependent mechanism drives antibodymediated target-receptor signaling in cancer cells
- Wilson, N.S., B. Yang, A. Yang, S. Loeser, S. Marsters, D. Lawrence, Y. Li, R. Pitti, K. Totpal, S. Yee, et al. 2011. An Fcγ receptor- dependent mechanism drives antibodymediated target-receptor signaling in cancer cells. Cancer Cell. 19:101-113. http://dx.doi .org/10.1016/j.ccr.2010.11.012
- (2011) Cancer Cell. , vol.19 , pp. 101-113
- Wilson, N.S.¹ Yang, B.² Yang, A.³ Loeser, S.⁴ Marsters, S.⁵ Lawrence, D.⁶ Li, Y.⁷ Pitti, R.⁸ Totpal, K.⁹ Yee, S.¹⁰

34
- 53749094183
- CTLA-4 control over Foxp3+ regulatory T cell function
- Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 322:271-275. http://dx.doi.org/ 10.1126/science.1160062
- (2008) Science. , vol.322 , pp. 271-275
- Wing, K.¹ Onishi, Y.² Prieto-Martin, P.³ Yamaguchi, T.⁴ Miyara, M.⁵ Fehervari, Z.⁶ Nomura, T.⁷ Sakaguchi, S.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.